Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Two conformations of the prion protein
- PrPSc amplification during disease propagation
- Protein misfolding cyclic amplification (PMCA)
- PMCA: proof of concept (1)
- PMCA: proof of concept (2)
- Automatized PMCA
- Increase in sensitivity of detection
- Application of PMCA to different samples
- Multiple applications of the PMCA technology
- Hypothesis for the nature of the infectious agent
- Compelling evidences for the prion hypothesis
- Can we generate infectious prions in vitro?
- Infinite replication of PrPSc in vitro
- In vitro produced PrPSc - identical to brain PrPSc
- Is in vitro generated PrPSc infectious?
- In vitro generated PrPSc is infectious
- Disease produced by in vitro generated PrPSc
- Prion strains (1)
- Prion strains (2)
- In vitro amplification of mouse prion strains
- In vitro generated strains are infectious
- Brain lesion profile
- Vacuolation profile
- Prions successfully amplified in vitro
- The dynamic nature of the species barrier
- Species barrier phenomenon
- Crossing species barrier in vitro
- Crossing mouse to hamster barrier in vitro
- In vitro replication of new RML-hamster PrPSc
- Infectivity of RML-hamster PrPSc
- Summary of properties of RML-hamster prions
- Crossing hamster to mouse barrier in vitro
- Prion strain adaptation by serial PMCA
- Summary of properties of 263-Mo prions
- Evaluating species barrier in vitro
- Importance of prion diagnosis (1)
- Importance of prion diagnosis (2)
- Ultrasensitive detection of PrPSc by PMCA (1)
- Ultrasensitive detection of PrPSc by PMCA (2)
- Detection of PrPSc in blood of sick animals
- Pre-symptomatic detection of PrPSc in blood
- Detection of PrPSc in urine of sick animals
- Conclusions
- Acknowledgments (1)
- Acknowledgments (2)
Topics Covered
- Prions as infectious proteins and the mechanism of replication
- The rationale and proof of concept for the PMCA technology
- Multiple applications of PMCA
- Generation of infectious prions by PMCA
- Studies of prion strains and species barrier
- Use of PMCA for prion detection and diagnosis
Talk Citation
Soto, C. (2020, May 1). Generation and propagation of infectious prions by cyclic amplification of protein misfolding [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/CVLA2115.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Claudio Soto has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Generation and propagation of infectious prions by cyclic amplification of protein misfolding
A selection of talks on Biochemistry
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Claudio Soto,
I'm Professor and Director of
the Mitchell Center for Neurodegenerative
Diseases at the Department of Neurology,
University of Texas Medical Branch.
I'll be talking today about the use of the
cyclic amplification of protein misfolding
for the generation and
propagation of infectious prions.
0:19
One of the unique characteristic of prion
diseases is that the prion protein can
exist in two different stages.
One is the normal prion protein that
we call PrPc, 'c' stands for cellular.
And this is a protein that we all have,
all healthy people or animals have.
The protein has a biological function,
mainly alpha-helicoidal,
sensitive to proteolysis and soluble.
However, the same protein with the same
sequence is also found in sick people or
animals with a different folding.
This is the so-called abnormal prion
protein, and we call it PrPSc.
This protein is supposed to be toxic and
infectious, is rich in beta-sheet
conformation, is resistant to proteolysis,
and is insoluble.
1:05
The infectious agent
associated to prion diseases,
is supposed to be composed exclusively by
the misfolded form of the prion protein,
PrPSc, here in the figure
represented in red squares.
The way that the misfolded prion
protein propagates a disease is by
transforming the normal
version of the protein PrPc,
represented in the figure in green
circles, gradually into its own.
Gradually from the normal form into
the misfolded form in a relatively slow
process to get to the point
in which sufficient amount
of the normal protein has been
transformed into the misfolded form, and
this will produce tissue damage and
disease.
The period between the infection time
to the time in which animals develop
the disease is called incubation time,
and this variable depends on the species.
For example, in rodents this
period can take several months,
in cattle, for example,
it can take several years, and
in the case of humans it
can take several decades.
Hide